US 11497740
Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
granted A61KA61K31/00A61K31/282
Quick answer
US patent 11497740 (Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer) held by The Board of Regents of the University of Texas System expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/00, A61K31/282, A61K31/337, A61K31/44